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Introduction
Defects involving the left ventricular outflow tract (LVOT) comprise a clinically significant group of congenital cardiovascular malformations. LVOT malformations, including bicuspid aortic valve (BAV), aortic valve stenosis (AVS), coarctation of the aorta (COA), and hypoplastic left heart syndrome (HLHS), are present in 1 in 1000 live births, and account for a significant portion of infant mortality [1] [2] [3] . Although the etiology of LVOT malformations is unclear, both environmental and genetic components play a role in disease pathogenesis. For example, prenatal exposure to solvents or high phenylalanine levels (secondary to maternal phenylketonuria) have been associated with higher incidence of LVOT malformations [4] . In addition, linkage analysis demonstrates a strong genetic component for these malformations. A non-parametric linkage analysis of LVOT malformation shows linkage to three chromosomes with overlapping linkage peaks suggesting a common genetic cause [5] . Mutations in NOTCH1 have been reported in two families with bicuspid aortic valve (BAV) and calcific AVS [6] , in sporadic BAV [7, 8] , and by our group in BAV, AVS, COA, and HLHS [9] . In support of the presumed common genetic pathogenic mechanism, we identified NOTCH1 missense variants in patients across the LVOT phenotypic spectrum and found that these alleles reduce liganddependent Notch signaling [9] .
Notch signaling is an evolutionarily conserved pathway that regulates cell fates and tissue formation during embryogenesis, including cardiac development [10, 11] . The NOTCH1 receptor is synthesized as a large polypeptide with 36 EGF-like repeats in the extracellular domain, three NOTCH/Lin repeats, a transmembrane domain, a transactivating domain, and intracellular domain with six ankyrin repeats to facilitate protein-protein interactions.
Mammalian NOTCH1 is synthesized as a single 300-kDa polypeptide in the endoplasmic Split (Hes) family of transcription factors [12] .
Recent research supports several important roles for Notch signaling during cardiac development. In the mouse, targeted deletion of Notch1 or its nuclear partner RBPJK/CBF1/Su(H) results in impaired epithelial-to-mesenchymal transition (EMT) during cardiac cushion development, leading to a collapsed endocardium and the absence of cushion cells in the mesenchyme [13] . Combined loss of Notch1 downstream targets, Hey1 and HeyL also causes impaired EMT in mice [14] . EMT occurs in the endocardium around E9.0 to form the cardiac cushions, and is critical for proper outflow tract and atrioventricular canal development. During cardiac EMT, endocardial cells undergo significant changes in gene expression including Notch1-dependent induction of -SMA, Snail1, and Snail2 [15, 16] . In addition to its role in EMT, recent data indicates that Notch signaling plays additional critical roles in both the neural crest and the secondary heart field during development [17, 18] .
In this study we examine the impact of LVOT associated NOTCH1 mutations on Notch processing and induction of EMT. Two previously identified missense NOTCH1 variants that reduce JAGGED-1 dependent Notch signaling are observed across a wide spectrum of LVOT phenotypes. One variant (NOTCH1 G661S ) was present in patients with AVS, CoA, and HLHS, as
well as in a patient with bicuspid aortic valve (BAV), reinforcing the idea of a common pathogenic mechanism. Interestingly, although these mutations are found at highly conserved sites within the NOTCH1 protein, alignment with other EGF repeats suggests that they might be well-tolerated substitutions. Indeed, all of these variants were also observed in an unaffected parent, so they can be tolerated in some developmental conditions. Given these conflicting findings, we examined the functional effects of these mutations on NOTCH1 protein maturation, trafficking and function, as well as their effects on the induction of EMT in endothelial cell lines, to determine how these missense variants might contribute to human disease.
Materials and Methods

Cell culture and plasmids.
NIH3T3 cells were cultured as previously described [9] . The HMEC-1 microvascular endothelial cell line was provided by the Centers for Disease Control and Prevention (Atlanta, Ga) and cultured as previously described [19] . Rat cDNAs encoding N-terminally HA-tagged rat NOTCH1, mutant NOTCH1 G661S , and mutant NOTCH1 A683T were described previously [9] .
GenBank Accession numbers are NM_017617.3 for human NOTCH1 and NM_001105721.1 for rat NOTCH1. Protein numbering reflects the initiation codon as codon 1.To generate stable NOTCH1 cell lines, 4 x 10 4 NIH3T3 cells were plated in 24 well plates and transfected using Lipofectamine 2000 with 0.8 g HA-tagged wild type or mutant NOTCH1 expression vectors.
Stable lines were generated by expanding individual colonies after culturing the cells for 15 days after transfection in the presence of G418 (0.6 mg/ml). NOTCH1 expression levels were determined by western blot. Cell lines exhibiting a range of NOTCH1 expression levels were expanded for use in further studies. Cell line exhibiting similar levels of wild type or mutant
NOTCH1 were maintained to facilitate comparison between cell lines.
Western Blot.
1. 5 x 10  5 NIH3T3 cells stably expressing NOTCH1, mutant NOTCH1  G661S , or mutant   NOTCH1 A683T were plated in 6 well plates. After 24 hours cells were lysed, run on a 6% SDS -PAGE gel, transferred to nitrocellulose, and NOTCH1 protein was detected with a mouse anti-HA antibody (HA-7, 1:1000, Sigma-Aldrich) and Alexafluor anti-mouse 688 secondary antibody
(1:20,000, Invitrogen). Band intensity was quantified using Li-Cor Odyssey 2.1 software. All exposures were in the linear range, as determined by this software. p300 and p180 bands were quantified, and the % of total protein cleaved was calculated as p180/(p180+p300). Each experiment was performed in triplicate and statistical analysis was performed (one way ANOVA, followed by Bonferroni post-hoc). Western blots after co-culture assays were performed essentially as above, using the following primary antibodies: SNAIL 1(Cell Signaling Technologies #3895 1:1000), SNAIL 2 (Cell Signaling Technologies #9585 1:500), Hey2
(Millipore #AB15632 1:1000), HEYL (Millipore #MAB10094, 1:1000) and -Tubulin (Sigma Aldrich T5168 1:1000). In some cases, western blots were developed using ECL plus, following the manufacturers recommendations. 
Results
S1-cleavage of the NOTCH1
A683T receptor is reduced.
The NOTCH1 G661S and NOTCH1 A683T variants cause impaired ligand-dependent Notch1 activation and are associated with LVOT malformations [9] .To determine the molecular cause of the impaired signaling, we examined whether these mutations affect NOTCH1 receptor processing. The NOTCH1 receptor is synthesized as a single 300-kDa polypeptide in the endoplasmic reticulum and cleaved (S1) by a furin convertase during posttranslational processing in the Golgi complex into p120 and p180 before its presentation at the cell surface. S1
cleavage has generally been believed to be required for CBF1 dependent Notch signaling, although more recent data suggests that there is not an absolute requirement for S1 cleavage in NOTCH1 [20, 21] . The reduction in ligand induced signaling when S1 cleavage is inhibited suggests that varints that reduce cleavage may exhibit reduced ligand-dependent signaling. S1
cleavage analysis in NIH3T3 cells transiently overexpressing wild type or variant NOTCH1
suggested that S1 cleavage was reduced in NOTCH1 A683T [9] . However, the high protein expression levels found in transient transfection can impair protein processing and trafficking, thus we confirmed and extended these observations in cell lines stably expressing varying amounts of NOTCH1 protein. Independent, stable cell lines were produced expressing
. Western blot analysis was used to select independent cell lines expressing varying amounts of NOTCH1 receptor to control for effects of protein expression levels.
Western blot analysis of cell lines stably expressing wild type or variant (G661S, A683T)
NOTCH1 reveals the presence of full length, unprocessed NOTCH1 as a band of 300 kDa and
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9 S1 processed NOTCH1 as a band of 180 kDa in all cell lines (Fig. 1B) . As suggested by previous work, we found that S1-processing is consistently reduced for NOTCH1
A683T
; the ratio of total protein processed (p180/(p180 +p300)) averaged .66 +/-.1 for the three wild-type NOTCH1
lines, but only .29 +/-.03 (p <.01) for the NOTCH1 A683T cell lines. In contrast, the ratio of total processed protein averaged .52 +/-.03 for the NOTCH1 G661S cell lines, indicating a slight but statistically insignificant reduction in S1 processing compared to wild type (Fig. 1B, C ). These data confirm and extend our previous findings, confirming that alterations in NOTCH1 A683T S1-processing are a result of the missense mutation and are not caused by protein overexpression.
Cell surface presentation of NOTCH1 G661S and NOTCH1 A683T is reduced.
Given the decrease in ligand-induced signaling of NOTCH1 G661S and NOTCH1
A683T mutants [9] , and the reduction of S1-cleaved NOTCH1
, the amount of mutant receptor present at the plasma membrane may be altered compared to wild type. To address this hypothesis, we performed cell-surface biotinylation experiments to directly assess receptor presentation on the cell surface. In cell lines stably expressing wild type NOTCH1 receptor, the majority of biotinylated receptors corresponded to the 180 kDa form ( Fig. 2A ), indicating that under our conditions only the S1 cleaved form efficiently reaches the cell surface. Likewise, the majority of biotinylated NOTCH1 G661S and NOTCH1 A683T receptors corresponded to the 180kDa form with significant amounts of p300 at the cell surface seen in only one NOTCH1 A683T line ( Fig. 2A) . Interestingly, the relative amounts of receptor on the cell surface were significantly reduced in NOTCH1 G661S and NOTCH1 A683T cell lines compared to lines expressing wild type receptor. The relative ratio of biotinylated receptor (expressed on the cell surface) to total amount of receptor protein was 1.05 +/-.04 for the three wild-type lines, whereas it was 0.38 +/-.1 (p <.01) for NOTCH1 G661S and 0.17 +/-.03 (p <.01) for NOTCH1 A683T expressing cell lines
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( Fig. 2A,B) . Thus, NOTCH1 receptors with mutations at either G661 or A683 are found at reduced levels on the cell surface compared to wild type receptors. In the NOTCH1 A683T mutation, this reduced cell surface presentation may be a secondary effect of reduced S1
cleavage. Further, since S1 cleavage of NOTCH1 G661S appears to be normal in our analyses, the molecular mechanism underlying the reduced cell surface expression may be distinct for each variant.
NOTCH1 A683T receptor protein accumulates in the endoplasmic reticulum
The decrease in S1 cleavage and the reduced levels of NOTCH1 A683T present at the cell surface compared to wild type could both result from impaired intracellular trafficking. For instance, it is possible that the observed reduction in S1 cleavage of NOTCH1 A683T could be a consequence of either impaired S1 cleavage in the Golgi, or of reduced transport of the receptor from the endoplasmic reticulum (ER) to the Golgi. To test these hypotheses, we analyzed NOTCH1 intracellular localization by immunofluorescence in cells stably expressing wild type or mutant receptors. In most cells expressing wild type NOTCH1, the receptor was found localized to small, cytoplasmic vesicle-like structures, and present at the cell surface, similar to previous descriptions [22] . Similar localization was observed in cell lines expressing NOTCH1 G661S . In contrast, the majority of cells expressing the variant NOTCH1 A683T receptor exhibited protein localization in the perinuclear region with a corresponding reduction in protein at the cell surface and in vesicle-like bodies. To quantify the mislocalization of NOTCH1 A683T , 100 cells from each cell line were counted, and classified as having protein largely in perinuclear regions (see, for example 3A. panels i, l) or having protein throughout the cell (Fig. 3A , panels a and j). Three independent experiments were performed for each cell line, demonstrating a significant increase in the number of cells with perinuclear protein staining for cells expressing receptor from the ER to the Golgi is impaired, leading to less protein present in the Golgi for S1
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
cleavage, and ultimately less protein presented at the cell surface. This suggests that the A683T mutation may impair proper protein folding, leading to the retention of the protein in the ER.
In contrast to our findings for NOTCH1 A683T protein, the localization pattern in the majority (68%) of cells expressing mutant NOTCH1 G661S was similar to that seen in wild type cells, although the cell surface expression was sometimes reduced (Fig. 3A: compare, for example, panel a with panel b), consistent with the biotinylation data reported above. We did not observe co-localization with Golgi markers in wild type NOTCH1, NOTCH1 G661S , or NOTCH A683T ( Fig. 3A: a-c), reflecting that NOTCH1 protein is only transiently present in the Golgi. Both wild type NOTCH1 and NOTCH1 G661S exhibited some co-localization with EEA1
and Rab7, although no significant differences were observed (Fig. 3A: g-i, j-l), indicating that endocytic processing of the mutant NOTCH1 G661S receptor is not demonstrably different than that of wild type NOTCH1 receptor. These findings reinforce the suggestion that distinct mechanisms underlie the reduction in ligand-induced Notch signaling observed in the NOTCH1 A683T and the NOTCH1 G661S variants.
NOTCH1 G661S and NOTCH1
A683T mutations cause reduced expression of Notch 12 responsive EMT Markers.
These findings, together with our previous report [9] demonstrate that the A683T and (Fig. 4B) . In addition, HEYL and HEY2 represent direct Notch targets that play important roles in cardiac EMT [14] . As observed for SNAIL1 and SNAIL2, we find that JAGGED1-responsive induction of both HEYL and HEY2 during EMT is significantly reduced in cells expression either NOTCH1 G661S or NOTCH1 A683T compared to cells expressing wild type NOTCH1 (Fig.   4 ). These data indicate that two LVOT-associated missense alleles, NOTCH1 G661S and NOTCH1 A683T , have an impaired ability to induce the expression of Notch-responsive markers of EMT.
NOTCH1 G661S and NOTCH1 A683T mutants exhibit impaired induction of EMT
In order to determine whether a partial reduction in Notch signaling can affect the efficiency of the cellular transition of endothelial to mesenchymal cell types, we performed coculture assays as described above followed by phase-contrast microscopy and 
Distinct molecular mechanisms may underlie the reduction in signaling through different mutant Notch1 receptors.
We have previously reported that missense variants in the human NOTCH1 gene identified in patients with LVOT defects are correlated with a reduction in ligand-induced CBF1-dependent Notch signaling [9] . Here we examine the molecular mechanism(s) that contribute to this reduction in signaling. The examined variants (NOTCH1 G661S and NOTCH1
A683T
) are found in neighboring EGF repeats (repeats 17 and 18), but our findings indicate that the underlying molecular cause of the reduction in signaling of these mutant receptors may be distinct.
We find that NOTCH1 A683T receptors exhibit both reduced S1 cleavage and a reduction in the amount of receptor found at the cell surface ( Figs. 1 and 2 ). Our data further indicate that
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15 mutant NOTCH1 A683T localizes to the ER in the majority of cells, in contrast to the usual NOTCH1 protein localization in small vesicle-like bodies, and at the cell surface. These data may indicate that the A683T mutation, which replaces a hydrophobic, nonpolar amino acid with a hydrophilic polar amino acid, interferes with proper protein folding, resulting in the retention of the misfolded protein in the ER. This retention, and the presumed subsequent degradation of misfolded protein would result in a reduced S1 cleavage, reduced cell surface presentation, and a subsequent reduction in ligand-induced signaling. There exists some precedent that missense mutations in EGF repeats can cause protein misfolding. For instance, the G274S mutation in JAGGED1 identified in patients with tetralogy of Fallot impairs folding of the EGF repeat [25] .
It may also be interesting to note that EGF repeat 18 is a reported substrate for fucosylation by the enzyme POFUT1 [26] . In Drosophila, Ofut1 protein possesses an essential, chaperone function that is required for stable, cell-surface expression of NOTCH [27] . In contrast, however, in mammalian cells POFUT1 is not required for cell surface expression, although fucosylation of Notch receptors is required for optimal ligand binding [28] In contrast to our findings for NOTCH1 A683T , we find that the NOTCH1 G661S variant does not overtly affect either folding or S1 processing. However, like NOTCH1 A683T , NOTCH1 G661S is found at reduced amounts at the cell surface (Figs 1 and 2 ). We presume that the reduced amount of receptor at the cell surface contributes to the observed reduction in ligand-induced signaling, but the mechanisms for this change in protein trafficking are not clear. G661 is found in EGF repeat 17, which has been reported to be modified by addition of an O-linked glucose [26] . In Drosophila, loss of the enzyme that catalyzes this modification causes a temperature sensitive Notch phenotype, and accumulation of the receptor on the cell surface [29] . The functions of EGF glucosylation in mammalian cells is poorly understood [30] . It is also possible that this
16 amino acid change interferes with other modifications of the receptor during intracellular processing. For instance, in mammalian cells, the E3 ubiquitin ligases Cbl and Itch/AIP4 have been shown to modify Notch but the biological importance of these alterations are currently not known [31, 32] . Some studies have shown that NOTCH1 cell surface expression is negatively regulated by the addition of ubiquitin signals during intracellular trafficking [33, 34] . Since ubiquitination is often linked to the endocytic pathway, it is possible that improper modifications to the mutant receptor lead to alterations in endocytic trafficking that are not noticeable by immunofluorescence, but which nonetheless affect receptor presentation at the cell surface.
These results suggest that diverse molecular mechanisms can perturb Notch1 signaling during cardiac development.
Reductions in ligand-induced Notch signaling can affect cell fate during EMT
The NOTCH1 variants identified in patients with LVOT malformations are predicted to reduce, but not abolish, Notch signaling. This implies that at least some of the processes during cardiac development that require Notch signaling will have dosage sensitive outcomes. We examined the function of the NOTCH1 A683T and NOTCH1 G661S variants during JAGGED1-induced EMT to determine whether the partial reductions we described in Notch signaling could influence cell fate decisions. EMT in the outflow tract cushions is necessary for proper formation of the aortic and pulmonary valves. In response to signals from the adjacent myocardium, the endocardium undergoes Notch-dependent EMT via upregulation of the Snail family of transcription factors [13, 16, 35, 36] . Mice with loss-of-function mutations in the Notch pathway display collapsed endocardium, lack mesenchymal cushion cells, and exhibit defective invasion of endocardial cells into the cardiac jelly, indicative of impaired EMT in the outflow tract [13, 14] . We find that endothelial cells that express mutant forms of the NOTCH1 receptor protein
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
17 exhibit reduced JAGGED1-dependent expression of critical EMT inducers Snail1, Snail2, and SMA, and well as reduced expression of the canonical Notch targets HEY2 and HEYL (Fig. 4) .
This reduction in the expression levels of critical mediators of EMT leads to an actual reduced efficiency in JAGGED1-induced EMT compared to cells expressing wild type NOTCH1 receptors (Fig. 5) . Thus our data support the hypothesis that relatively small reductions in NOTCH1 signaling can adversely affect key processes in cardiac development. These findings support the proposal that reduced Notch signaling and the resulting reduction in the efficiency of EMT could serve as a unifying event whereby Notch mutations contribute to diverse LVOT malformations.
The Notch pathway plays multiple roles during outflow tract development.
Although impaired EMT in the outflow tract may provide a unifying pathogenesis for diverse LVOT malformations, there are several additional cardiac developmental processes that may be sensitive to reductions in Notch1 signaling. Dosage sensitivity in any of these developmental decisions could also contribute to cardiac defects in patients carrying Notch1 variant proteins. The outflow tract is generated by interactions among many different cell types, including cardiomyocytes, neural crest derived cells, the secondary heart field, and endothelial cells. Neural crest derived cells give rise to the smooth muscle layer of the aorta and pulmonary artery and contribute to the semilunar valve leaflets. Notch signaling is essential for the differentiation of cardiac neural crest progenitors into smooth muscle cells in vivo, as blocking Notch signaling in the derivatives of the cardiac neural crest results in stenosis of the vessels and aortic arch defects resembling that seen in Alagille syndrome [17] . The smooth muscle layer is believed to be critical for maintaining the structure of the arteries, indicating that defects in Notch signaling resulting from LVOT-associated NOTCH1 alleles in neural crest derived cells
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18 could contribute to CoA, which results from a narrowing of the aorta. In addition, recent work has demonstrated that altering Notch signaling levels in cardiomyocytes can result in cardiac defects [37] .
Notch signaling in the second heart field is also important for proper outflow tract development. The second heart field is a group of mesoderm derived cells that migrate from the anterior pharynx into the heart and give rise to the myocardium of the outflow tract, right ventricle, interventricular septum, part of the atria, and smooth muscle at the bottom of the outflow vessels [38] [39] [40] [41] [42] [43] . Recent work demonstrates that JAGGED1-dependent Notch signaling in the second heart field regulates the migration of neighboring neural crest cells, and EMT in the endocardial cushions [18] . Together, these data indicate that Notch plays multiple roles in tissue-tissue interactions during outflow tract development, representing additional mechanisms where reductions in Notch signaling could perturb outflow tract development. It is not unreasonable to suggest that as we have seen during EMT, reductions in Notch signaling due to missense mutations such as G661S or A683T may affect the efficiency of other cell fate decisions that are critical to outflow tract development.
Reductions in Notch signaling may sensitize outflow tract development to other genetic and environmental insults
It is important to remember that the NOTCH1 variants identified in patients with LVOT malformations are not sufficient to cause cardiac defects. In all cases, the identical variant was found in an unaffected parent [9] . One attractive explanation for this finding would be that these missense variants, which lead to reductions, but not loss, of Notch signaling, act to sensitize outflow tract development to other genetic or environmental insults. This hypothesis is especially intriguing in light of the fact that cells expressing mutant NOTCH1 receptors exhibit a reduction
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19 in the efficiency of EMT, but not a block to the process. In the context of embryonic development, this partial reduction might lead to a developmental window during which other genetic or environmental insults could synergize with the reduction in EMT to perturb development of the outflow tract in some individuals. In other cases, in the absence of additional perturbations, the level of EMT driven by these mutant receptors might be sufficient to support normal cardiac development, explaining the presence of unaffected carriers of the variants. Some precedent exists for this idea. Snail2-deficient mouse embryos exhibit defective EMT at E9.5, which might be considered equivalent to the reductions in EMT efficiency we observe in endothelial cells expressing variant NOTCH1 receptors. However, in Snail2 deficient embryos, EMT recovers by E10.5 due to an increase in Snail1 expression [15] . It is attractive to hypothesize that this transient deficiency during early outflow tract development could sensitize the tissue to other environmental or genetic insults. The severity of these additional insults may determine whether a specific NOTCH1 variant leads to a simple bicuspid aortic valve or severe hypoplastic left heart syndrome. Intriguingly, recent findings from the Stanley lab indicate that reductions in Notch signaling may act stochastically, or in combination with genetic background to produce phenotypic outcomes of varying severity. Specifically, they find that the combination of the Notch1 12f hypomorphic allele with a Notch1 null allele produces embryos of the genotype Notch1 12f/-with a wide variation in phenotype [44] . Similarly, individuals carrying a single copy of a NOTCH1 missense mutation may be at heightened risk for cardiac malformations, dependent on genetic background or environmental effects.
This study elucidates the molecular mechanisms by which missense mutations in the NOTCH1 receptor can contribute to LVOT malformations. We find that two LVOT associated NOTCH1 alleles reduce Jagged-1 dependent Notch1 signaling by altering protein folding and 
